Lymperopoulos, Anastasios <br/><br/>
Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.  [electronic resource] 

 -  Journal of the American College of Cardiology  Jan 2011 
 - 356-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-3597 
<br/><br/><label>Standard No.: </label>10.1016/j.jacc.2010.08.635  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Glands--drug effects<br/>Aldosterone--biosynthesis<br/>Animals<br/>Arrestins--antagonists & inhibitors<br/>Cell Line<br/>Disease Progression<br/>Gene Transfer Techniques<br/>Heart Failure--blood<br/>Humans<br/>Losartan--pharmacology<br/>Myocardial Infarction--blood<br/>Random Allocation<br/>Rats<br/>Receptors, G-Protein-Coupled--antagonists & inhibitors<br/>Ventricular Remodeling--drug effects<br/>beta-Arrestin 1<br/>beta-Arrestins